Literature DB >> 32045325

Assessment of Contraceptive Needs and Improving Access in the U.S.-Affiliated Pacific Islands in the Context of Zika.

Caitlin Green1, Charity Ntansah2, Meghan T Frey1, Jamie W Krashin3,4, Eva Lathrop3,5, Lisa Romero3.   

Abstract

Scientific evidence demonstrated a causal relationship between Zika virus infection during pregnancy and neurologic abnormalities and other congenital defects. The U.S. government's Zika Virus Disease Contingency Response Plan recognized the importance of preventing unintended pregnancy through access to high-quality family planning services as a primary strategy to reduce adverse Zika-related birth outcomes during the 2016-2017 Zika virus outbreak. The U.S.-affiliated Pacific Islands (USAPI) includes three U.S. territories: American Samoa, the Commonwealth of the Northern Mariana Islands, and Guam, and three independent countries in free association with the United States: the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Aedes spp. mosquitoes, the primary vector that transmits Zika virus, are common across the Pacific Islands, and in 2016, laboratory-confirmed cases of Zika virus infection in USAPI were reported. CDC conducted a rapid assessment by reviewing available reproductive health data and discussing access to contraception with family planning providers and program staff in all six USAPI jurisdictions between January and May 2017. In this report, we summarize findings from the assessment; discuss strategies developed by jurisdictions to respond to identified needs; and describe a training that was convened to provide technical assistance to USAPI. Similar rapid assessments may be used to identify training and technical assistance needs in other emergency preparedness and response efforts that pose a risk to pregnant women and their infants.

Entities:  

Keywords:  USAPI; Zika; contraception; preparedness

Mesh:

Substances:

Year:  2020        PMID: 32045325      PMCID: PMC8237938          DOI: 10.1089/jwh.2020.8302

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  18 in total

Review 1.  The point of triangulation.

Authors:  V A Thurmond
Journal:  J Nurs Scholarsh       Date:  2001       Impact factor: 3.176

2.  Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas.

Authors:  Margaret L Vaaler; Lauri K Kalanges; Vincent P Fonseca; Brian C Castrucci
Journal:  Womens Health Issues       Date:  2012-01-21

3.  Differences in Family Planning Services by Rural-urban Geography: Survey of Title X-Supported Clinics In Great Plains and Midwestern States.

Authors:  Summer L Martins; Katherine A Starr; Wendy L Hellerstedt; Melissa L Gilliam
Journal:  Perspect Sex Reprod Health       Date:  2016-02-03

4.  Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs.

Authors:  Loretta Gavin; Susan Moskosky; Marion Carter; Kathryn Curtis; Evelyn Glass; Emily Godfrey; Arik Marcell; Nancy Mautone-Smith; Karen Pazol; Naomi Tepper; Lauren Zapata
Journal:  MMWR Recomm Rep       Date:  2014-04-25

5.  Preventing unintended pregnancies by providing no-cost contraception.

Authors:  Jeffrey F Peipert; Tessa Madden; Jenifer E Allsworth; Gina M Secura
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

6.  U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

Authors:  Kathryn M Curtis; Tara C Jatlaoui; Naomi K Tepper; Lauren B Zapata; Leah G Horton; Denise J Jamieson; Maura K Whiteman
Journal:  MMWR Recomm Rep       Date:  2016-07-29

7.  Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.

Authors:  Sheree L Boulet; Denise V D'Angelo; Brian Morrow; Lauren Zapata; Erin Berry-Bibee; Maria Rivera; Sascha Ellington; Lisa Romero; Eva Lathrop; Meghan Frey; Tanya Williams; Howard Goldberg; Lee Warner; Leslie Harrison; Shanna Cox; Karen Pazol; Wanda Barfield; Denise J Jamieson; Margaret A Honein; Charlan D Kroelinger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-05       Impact factor: 17.586

8.  Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response - United States, September 2016.

Authors:  Charlan D Kroelinger; Lisa Romero; Eva Lathrop; Shanna Cox; Isabel Morgan; Meghan T Frey; Lee Warner; Kathryn M Curtis; Karen Pazol; Wanda D Barfield; Dana Meaney-Delman; Denise J Jamieson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-11-10       Impact factor: 17.586

9.  State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.

Authors:  Charlan D Kroelinger; Marion E Rice; Shanna Cox; Hadley R Hickner; Mary Kate Weber; Lisa Romero; Jean Y Ko; Donna Addison; Trish Mueller; Carrie Shapiro-Mendoza; S Nicole Fehrenbach; Margaret A Honein; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-09-13       Impact factor: 17.586

10.  The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.

Authors:  Eva Lathrop; Lisa Romero; Stacey Hurst; Nabal Bracero; Lauren B Zapata; Meghan T Frey; Maria I Rivera; Erin N Berry-Bibee; Margaret A Honein; Judith Monroe; Denise J Jamieson
Journal:  Lancet Public Health       Date:  2018-01-19
View more
  1 in total

1.  Community Perspectives on Contraception in the Context of Zika Virus in American Samoa and the Commonwealth of the Northern Mariana Islands.

Authors:  Lisa Romero; Rachel Powell; Charity Ntansah; Hailey Bednar; Caitlin Green; Anna Brittain; Ruben Torrez; Irene Barrineau; Heather S Pangelinan; Ianeta Timoteo-Liaina; Luis Garcia; Eva Lathrop
Journal:  Hawaii J Health Soc Welf       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.